OOIR: Observatory of International Research

Papers

(The H4-Index of Cancer Medicine is 40. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
	162
Estimating the overall survival benefit of adjuvant chemo‐endocrine therapy in women over age 50 with pT1‐2N0 early stage breast cancer and 21‐gene recurrence score ≥26: A Nation	102
Efficacy and safety of irinotecan combined with raltitrexed or irinotecan monotherapy for salvage chemotherapy of esophageal squamous cell cancer: A prospective, open label, randomized phase II	100
Pulmonary lymphangitis carcinomatosis: A peculiar presentation clustering in MET‐amplified gastric cancer	94
Hepatic failure associated with immune checkpoint inhibitors: An analysis of the Food and Drug Administration Adverse Event Reporting System database	94
Body mass index and incident cardiometabolic conditions in relation to obesity‐related cancer risk: A population‐based cohort study in Catalonia, Spain	90
Immune checkpoint gene VSIR predicts patient prognosis in acute myeloid leukemia and myelodysplastic syndromes	78
Soluble form of CTLA‐4 is a good predictor for tumor recurrence after radiofrequency ablation in hepatocellular carcinoma patients	78
Incidence and prognostic impact of U2AF1 mutations and other gene alterations in myelodysplastic neoplasms with isolated 20q deletion	77
Cancer and the family: Variations by sex and race/ethnicity	71
A Study to Assess the Dosimetric Impact of the Anatomical Changes Occurring in the Parotid Glands and Tumour Volume during Intensity Modulated Radiotherapy using Simultaneous Integrated Boost (IMRT‐SI	62
Mobilization of hematopoietic stem cells with lenograstim in multiple myeloma patients: Prospective multicenter observational study (KMM122)	60
Re‐irradiation in patients with progressive or recurrent brain metastases from extracranial solid tumors: A novel prognostic index	60
Inflammatory geriatric nutritional risk index stratified the survival of older adults with cancer sarcopenia	60
Predicting cervical lymph node metastasis in OSCC based on computed tomography imaging genomics	56
Effect modification of age and hypertension on cancer and prevalence of self‐reported stroke – A cross‐sectional study	56
An online randomised controlled trial of prognosticating imminent death in advanced cancer patients: Clinicians give greater weight to advice from a prognostic algorithm than from another clinician wi	56
Fragility of randomized trials supporting cancer drug approvals stratified by approval pathway and review designations	54
Cost‐effectiveness analysis of tumor‐infiltrating lymphocytes biomarkers guiding chemotherapy de‐escalation in early triple‐negative breast cancer	51
The effect of body mass index on quality of life in modified single stoma cutaneous ureterostomy or ileal conduit after radical cystectomy	49
Clinical results of active surveillance for extra‐abdominal desmoid‐type fibromatosis	48
Exploration of the breast ductal carcinoma in situ signature and its prognostic implications	47
Genomic alteration profile and PD‐L1 expression among different breast cancer subtypes in Chinese population and their correlations	47
Impact of skeletal muscle volume on patients with BCLC stage‐B hepatocellular carcinoma undergoing sorafenib therapy	46
Issue Information	45

Impact of the model of long‐term follow‐up care on adherence to guideline‐recommended surveillance among survivors of adolescent and young adult cancers	45
Identifying metrics of success for transitional care practices in childhood cancer survivorship: A qualitative interview study of parents	45
Intensified conditioning regimens with total marrow irradiation/etoposide/cyclophosphamide and busulfan/etoposide/cyclophosphamide overcome the impact of pre‐transplant minimal residual disease on out	45
Feasibility of supervised telehealth exercise for patients with advanced melanoma receiving checkpoint inhibitor therapy	45
Establishing a robust radioligand therapy program: A practical approach for North American centers	43
Educational outcomes in siblings of childhood leukemia survivors: Factors associated with school difficulties and comparison with general population	43
Characteristics of anal canal cancer in Japan	43
Longitudinal Trends of Comorbidities and Survival Among Kidney Cancer Patients in Asian Population	42
Integrated analysis identifies a novel lncRNA prognostic signature associated with aerobic glycolysis and hub pathways in breast cancer	42
Impact of intra‐tumoral immunity on predicting response and survival after neoadjuvant cisplatin‐based chemotherapy in patients with muscle invasive bladder cancer	41
SARC‐F as a screening tool to detect computed tomography‐based sarcopenia and myosteatosis among older adults with cancer	41
Racial and ethnic disparities in mortality among World Trade Center Health Registry enrollees with post‐9/11 cancer	40
SIRT2 inhibitor SirReal2 enhances anti‐tumor effects of PI3K/mTOR inhibitor VS‐5584 on acute myeloid leukemia cells	40
Front‐line treatment efficacy and clinical outcomes of elderly patients with multiple myeloma in a real‐world setting: A multicenter retrospective study in China	40
Differences in sensitivity to new therapies between primary and metastatic breast cancer: A need to stratify the tumor response?	40